---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-010458"
form_type: "8-K"
ticker: "BCAB"
cik: "0001826892"
company_name: "BioAtla, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:56:36.268220+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# BioAtla issues super-voting share to CEO; reverse stock split vote fails, adjourned to Jan 26

## Summary
- Issued one share of Series A Junior Preferred Stock to CEO Jay Short for $0.01, granting vote power equal to outstanding common shares on reverse split proposals.
- At Jan 12, 2026 special meeting, reverse stock split proposal failed to reach required two-thirds vote; meeting adjourned to Jan 26 for additional proxy solicitation.
- Over 70% of proxies received were FOR the reverse split, but insufficient to meet two-thirds of outstanding voting power.
- Super-Voting Share will automatically vote FOR the reverse split if two-thirds of common shares present vote FOR; else votes AGAINST.
- Board set new record date of Jan 12, 2026 for the reconvened meeting.

## SEC filing metadata
- accession: 0001193125-26-010458
- form_type: 8-K
- ticker: BCAB
- cik: 0001826892
- company_name: BioAtla, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.02, 5.03, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/bcab-20260109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-010458
- JSON: https://secwatch.observer/filing/0001193125-26-010458.json
- Plain text: https://secwatch.observer/filing/0001193125-26-010458.txt

## Source-grounded claims
- claim_id: 61761be4c430dc01f28b68d35a57826f45858c08
  claim: BioAtla, Inc.: Filed Certificate of Designation for Series A Junior Preferred Stock (Super-Voting Share) establishing its voting, dividend, liquidation, redemption, and transfer terms (effective 2026-01-09).
  evidence_excerpt: On January 9, 2026, the Company filed a Certificate of Designation of Series A Junior Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware with respect to the Super-Voting Share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826892/000119312526010458/0001193125-26-010458-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.